NASDAQ:CPIX
Cumberland Pharmaceuticals Inc. Stock News
$1.51
+0.0100 (+0.667%)
At Close: May 17, 2024
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2024 Earnings Call Transcript
11:51pm, Saturday, 11'th May 2024
Start Time: 15:30 January 1, 0000 3:59 PM ET Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2024 Earnings Conference Call May 07, 2024, 15:30 PM ET Company Participants A.J. Kazimi - CEO Todd Antho
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
04:05pm, Tuesday, 07'th May 2024
NASHVILLE, TENN., May 7, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced that its product portfolio of FDA-approved brands deli
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
04:05pm, Tuesday, 30'th Apr 2024
NASHVILLE, Tenn. , April 30, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2024 financ
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
04:05pm, Tuesday, 02'nd Apr 2024
Growing data shows intravenous ibuprofen is safe and effective for the treatment of pain and fever in adults, children and infants NASHVILLE, Tenn. , April 2, 2024 /PRNewswire/ -- Cumberland Pharmace
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
10:06pm, Tuesday, 05'th Mar 2024
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman an
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
04:05pm, Tuesday, 05'th Mar 2024
2023 highlights include expanded FDA approval and new study publications NASHVILLE, Tenn. , March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical co
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
04:05pm, Tuesday, 27'th Feb 2024
NASHVILLE, Tenn. , Feb. 27, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2023 financial res
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2023 Earnings Call Transcript
08:17am, Saturday, 11'th Nov 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
04:05pm, Tuesday, 07'th Nov 2023
NASHVILLE, Tenn. , Nov. 7, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands de
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
04:05pm, Tuesday, 31'st Oct 2023
NASHVILLE, Tenn., Oct. 31, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the third quarter 2023 financ
NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
04:05pm, Tuesday, 10'th Oct 2023
NASHVILLE, Tenn. , Oct. 10, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agents and Chemotherapy 1 detailing the results of th
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2023 Earnings Call Transcript
04:21am, Saturday, 12'th Aug 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Molly Aggas - IR A.J. Kazimi - CEO Todd Anthony - VP, Organizational Deve
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
04:05pm, Tuesday, 08'th Aug 2023
NASHVILLE, Tenn. , Aug. 8, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results and a favo
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS
04:05pm, Tuesday, 01'st Aug 2023
NASHVILLE, Tenn. , Aug. 1, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the second quarter 2023 financ
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2023 Earnings Call Transcript
05:45pm, Saturday, 13'th May 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Julia Motis - Senior Account Manager, Dalton Agency A.J. Kazimi - CEO Todd A
